The fastest screening tool for peripheral arterial disease
It is everything that you are looking for in a medical device – a fast, simple, accurate and objective screening tool for the diagnosis of peripheral arterial disease.
Primary health care
Primary care physicians are in a pivotal position within the healthcare system to improve the standard of care for patients with PAD. This improvement can be achieved if physicians follow guidelines and measure ABI on all patients in cardiovascular risk group, regardless of presenting symptoms.
According to 2017 ESC Guidelines, individuals who are at risk for PAD:
-Men and women over 50 years of age with family history for PAD
-Men and women younger then 65 years of age with cardiovascular risk factors (hypertensive, overweight, diabetic, smokers)
-Everyone over 65 years of age.
Secondary health care
Measurements of the Ankle-Brachial Index may improve the accuracy of cardiovascular risk prediction beyond the Framingham Risk Score. Furthermore, ABI is valuable for assessing the ability of rehabilitation after cardiac procedures or treatment.
A screening ABI should be considered in diabetic patients above 50 years of age who have other PAD risk factors (e.g., smoking, hypertension, hyperlipidemia, or duration of diabetes for 10 years). If ABI is normal, the measurement has to be repeater every five years.
ABI is used as screening tool to determine the possible presence of PAD and therefore indicate further management. It is especially useful in post-operative care of revascularized patients.
Kidney disease is an independent risk factor for the development of PAD. According to KDOQI guidelines, all patients should be evaluated for PAD at the time of dialysis. The disease in those patients progresses faster than in patients without kidney disease.
Dermatology/Compression therapy and wound care
Ankle-Brachial Index should be the first measurement in wound care, to predict the heal-ability of lower leg wounds. It rules out arterial condition and therefore determine safe level of compression.
Measurements of the Ankle-Brachial Index contribute to correct indications for surgical therapy and are mandatory in the follow up of patients after surgical treatment.
Measurements of the Ankle-Brachial Index are essential in differential diagnosis of lower extremity pain. In addition, a recurrent ischemia associated with PAD may cause muscle denervation, which may be one of the mechanisms responsible for decreased exercise performance in these patients.
Measurements of the Ankle-Brachial Index (ABI) are essential in differential diagnosis of lower extremity pain.